Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1949 4
1950 2
1951 4
1952 3
1955 1
1956 2
1958 4
1959 1
1960 2
1961 2
1962 3
1963 1
1964 4
1965 2
1966 3
1967 3
1968 4
1969 5
1970 5
1971 4
1972 1
1973 8
1974 3
1975 5
1976 5
1977 6
1978 3
1979 7
1980 8
1981 5
1982 3
1983 2
1984 8
1985 7
1986 7
1987 3
1988 2
1989 15
1990 10
1991 8
1992 8
1993 4
1994 4
1995 6
1996 2
1997 4
1998 5
1999 3
2000 6
2001 8
2002 5
2003 4
2004 4
2005 3
2006 6
2007 6
2008 9
2009 3
2010 7
2011 6
2012 2
2013 3
2014 7
2015 4
2016 7
2017 12
2018 12
2019 7
2020 13
2021 21
2022 17
2023 9
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

376 results

Results by year

Filters applied: . Clear all
Page 1
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.
Chi KN, Agarwal N, Bjartell A, Chung BH, Pereira de Santana Gomes AJ, Given R, Juárez Soto Á, Merseburger AS, Özgüroğlu M, Uemura H, Ye D, Deprince K, Naini V, Li J, Cheng S, Yu MK, Zhang K, Larsen JS, McCarthy S, Chowdhury S; TITAN Investigators. Chi KN, et al. N Engl J Med. 2019 Jul 4;381(1):13-24. doi: 10.1056/NEJMoa1903307. Epub 2019 May 31. N Engl J Med. 2019. PMID: 31150574 Free article. Clinical Trial.
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H, Lopez-Gitlitz A, Trudel GC, Espina BM, Shu Y, Park YC, Rackoff WR, Yu MK, Small EJ; SPARTAN Investigators. Smith MR, et al. N Engl J Med. 2018 Apr 12;378(15):1408-1418. doi: 10.1056/NEJMoa1715546. Epub 2018 Feb 8. N Engl J Med. 2018. PMID: 29420164 Free article. Clinical Trial.
Editorial Comment.
Frankel JM. Frankel JM. Urol Pract. 2024 Mar;11(2):392-393. doi: 10.1097/UPJ.0000000000000502.02. Epub 2024 Jan 10. Urol Pract. 2024. PMID: 38215019 No abstract available.
Editorial Commentary.
Wong D, Frankel J. Wong D, et al. Among authors: frankel j. Urol Pract. 2022 Nov;9(6):586-587. doi: 10.1097/UPJ.0000000000000336.02. Epub 2022 Sep 1. Urol Pract. 2022. PMID: 37145828 No abstract available.
Reply by Authors.
Staskin D, Frankel J, Varano S, Shortino D, Jankowich R, Mudd PN Jr. Staskin D, et al. Among authors: frankel j. J Urol. 2021 May;205(5):1429. doi: 10.1097/JU.0000000000001574.02. Epub 2021 Mar 9. J Urol. 2021. PMID: 33687277 No abstract available.
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.
Lopes RD, Higano CS, Slovin SF, Nelson AJ, Bigelow R, Sørensen PS, Melloni C, Goodman SG, Evans CP, Nilsson J, Bhatt DL, Clarke NW, Olesen TK, Doyle-Olsen BT, Kristensen H, Arney L, Roe MT, Alexander JH; PRONOUNCE Study Investigators. Lopes RD, et al. Circulation. 2021 Oct 19;144(16):1295-1307. doi: 10.1161/CIRCULATIONAHA.121.056810. Epub 2021 Aug 30. Circulation. 2021. PMID: 34459214 Free PMC article. Clinical Trial.
Reply by Authors.
Staskin D, Frankel J, Varano S, Shortino D, Jankowich R, Mudd PN Jr. Staskin D, et al. Among authors: frankel j. J Urol. 2020 Aug;204(2):324. doi: 10.1097/JU.0000000000000807.03. Epub 2020 May 21. J Urol. 2020. PMID: 32436760 No abstract available.
Editorial Commentary.
Frankel JM. Frankel JM. Urol Pract. 2023 May;10(3):252. doi: 10.1097/UPJ.0000000000000392.01. Epub 2023 Mar 13. Urol Pract. 2023. PMID: 37103507 No abstract available.
Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial.
Gray R, Patel S, Ives N, Rick C, Woolley R, Muzerengi S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE; PD MED Collaborative Group. Gray R, et al. JAMA Neurol. 2022 Feb 1;79(2):131-140. doi: 10.1001/jamaneurol.2021.4736. JAMA Neurol. 2022. PMID: 34962574 Free PMC article. Clinical Trial.
376 results